Sale!

GNA11 Gene Hypocalcemia Autosomal Dominant 2 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “GNA11 Gene Hypocalcemia Autosomal Dominant 2 Genetic Test” is a specialized diagnostic examination aimed at identifying mutations in the GNA11 gene, which are linked to Autosomal Dominant Hypocalcemia Type 2 (ADH2). This condition is characterized by low calcium levels in the blood, which can lead to a variety of symptoms including numbness, muscle cramps, seizures, and abnormal heart rhythms. The GNA11 gene plays a crucial role in the regulation of calcium levels within the body, and mutations in this gene disrupt this balance, leading to the symptoms associated with ADH2.

The test is performed at DNA Labs UAE, a reputable genetic testing facility known for its advanced diagnostic technologies and expert staff. The cost of the test is 4400 AED, which reflects the comprehensive analysis and the specialized nature of this genetic examination. Individuals who have a family history of hypocalcemia or exhibit symptoms associated with calcium imbalance may be recommended to undergo this test. Early diagnosis through the GNA11 gene test can facilitate better management of the condition, potentially preventing severe complications associated with hypocalcemia.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

GNA11 Gene Hypocalcemia Autosomal Dominant 2 Genetic Test

At DNA Labs UAE, we offer the GNA11 Gene Hypocalcemia autosomal dominant 2 Genetic Test. This test is designed to detect mutations or variations in the GNA11 gene that may be responsible for autosomal dominant hypocalcemia type 2. It can provide valuable information for diagnosis, treatment, and family planning purposes.

Test Details

The GNA11 gene is associated with autosomal dominant hypocalcemia type 2, a condition characterized by low levels of calcium in the blood. Symptoms of this condition may include muscle cramps, numbness or tingling in the extremities, seizures, and abnormal heart rhythms.

Our GNA11 Gene Hypocalcemia autosomal dominant 2 Genetic Test utilizes NGS (Next-Generation Sequencing) technology. This advanced genetic testing method allows for rapid sequencing of large amounts of DNA, enabling us to identify any mutations or variations in the GNA11 gene that may be present.

Test Components and Price

Our GNA11 Gene Hypocalcemia autosomal dominant 2 Genetic Test is priced at 4400.0 AED.

The test requires a sample of either blood, extracted DNA, or one drop of blood on an FTA Card.

Once the sample is received, the report delivery time is typically 3 to 4 weeks.

Test Type and Department

The GNA11 Gene Hypocalcemia autosomal dominant 2 Genetic Test falls under the category of Metabolic Disorders. It is conducted by our Genetics department.

Pre-Test Information

Prior to the test, it is important to provide the clinical history of the patient who is undergoing the GNA11 Gene Hypocalcemia autosomal dominant 2 NGS Genetic DNA Test. Additionally, a genetic counseling session is recommended to draw a pedigree chart of family members affected by Hypocalcemia autosomal dominant 2.

Doctor and Method

Our GNA11 Gene Hypocalcemia autosomal dominant 2 Genetic Test is conducted under the supervision of a General Physician. The method used is NGS (Next-Generation Sequencing) technology.

Benefits of Genetic Testing

Genetic testing can be beneficial for individuals experiencing symptoms of hypocalcemia and have a family history of the condition. It can help guide treatment and management decisions, as well as provide valuable information for genetic counseling and family planning purposes.

Important Considerations

It is crucial to undergo genetic testing under the guidance of a healthcare professional who specializes in genetics. They can help interpret the results and provide appropriate counseling and support.

Test Name GNA11 Gene Hypocalcemia autosomal dominant 2 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Metabolic Disorders
Doctor General Physician
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for GNA11 Gene Hypocalcemia, autosomal dominant 2 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Hypocalcemia, autosomal dominant 2
Test Details

The GNA11 gene is associated with a condition called autosomal dominant hypocalcemia type 2. This condition is characterized by low levels of calcium in the blood, which can lead to symptoms such as muscle cramps, numbness or tingling in the extremities, seizures, and abnormal heart rhythms.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced technology to rapidly sequence large amounts of DNA. It can be used to identify mutations or variations in the GNA11 gene that may be responsible for autosomal dominant hypocalcemia type 2.

This genetic test involves obtaining a sample of the individual’s DNA, typically through a blood sample or a cheek swab. The DNA is then sequenced using NGS technology to identify any mutations or variations in the GNA11 gene. The results of the test can help confirm a diagnosis of autosomal dominant hypocalcemia type 2 and provide information about the specific genetic variant causing the condition.

Genetic testing can be useful for individuals with symptoms of hypocalcemia and a family history of the condition, as it can help guide treatment and management decisions. It can also be used for genetic counseling and family planning purposes.

It is important to note that genetic testing should be done under the guidance of a healthcare professional who specializes in genetics, as they can help interpret the results and provide appropriate counseling and support.